TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Astragaloside IV, Bevacizumab
Phytochemical Name Astragaloside IV (PubChem CID: 13943297 )
Anticancer drug Name Bevacizumab (PubChem CID: / )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 186
Pair Name Astragaloside IV, Bevacizumab
Disease Info [ICD-11: 2C25] Lung cancer Investigative
Biological Phenomena Induction-->Apoptosis
Gene Regulation Up-regulation Phosphorylation AKT1 hsa207
Up-regulation Expression BAX hsa581
Down-regulation Expression BCL2 hsa596
Down-regulation Expression BECN1 hsa8678
Up-regulation Cleavage CASP3 hsa836
Up-regulation Phosphorylation MTOR hsa2475
Up-regulation Expression SQSTM1 hsa8878
In Vitro Model A-549 Lung adenocarcinoma Homo sapiens (Human) CVCL_0023
Result This paper demonstrates that AST-IV enhances the effect of BV on inhibiting proliferation and promoting apoptosis of lung adenocarcinoma cells through inhibiting autophagy pathway.
03. Reference
No. Title Href
1 Astragaloside IV enhances the sensibility of lung adenocarcinoma cells to bevacizumab by inhibiting autophagy. Drug Dev Res. 2022 Apr;83(2):461-469. doi: 10.1002/ddr.21878. Click
It has been 26700 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP